ClinicalTrials.govpublic full text
Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19
covid19, dexamethasone, sars cov-2 infection, covid-19, severe acute respiratory syndrome, nasal administration, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 880903
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.